Patient Guide: A Phase I/II observer-blind, randomized, multi-center trial to evaluate the safety and immunogenicity of different formulations of monovalent Influenza A/Astrakhan/3212/2020 like (H5N8) virus vaccine with AS03 adjuvant system (referred to as Q-Pan H5N8), given as a two-dose series to adults 18 to 64 years of age and 65 years of age and older

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 20 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05975840
Status: COMPLETED_NEXT_PHASE_UPCOMING
Condition: Influenza, Human
Phase: Phase I, Phase II

Find a Study Location Near You

This study is available at 20 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Tempe, AZ
  • Anderson, SC
  • Anniston, AL
  • • And 17 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily